You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG asparaginase

Showing 1 - 25 of 1,016
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity of First Doses of PEG-Asparaginase -An

Recruiting
  • Acute Lymphoblastic Leukemia
    • Aarhus N, Denmark
    • +1 more
    Jan 25, 2023

    Treatment With Steroids and PEG- Asparaginase in Children and

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • +3 more
      • Aarhus N, Denmark
        Aarhus University Hospital
      May 15, 2023

      Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Hyperbilirubinemia
      • Levocarnitine
      • Vitamin B Complex
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 7, 2022

      B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • +5 more
      • Biospecimen Collection
      • +4 more
      • (no location specified)
      Oct 28, 2022

      Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

      Recruiting
      • Acute Lymphoid Leukemia
      • +3 more
      • São Paulo, SP, Brazil
        Instituto do Cancer do Estado de Sao Paulo
      Jul 24, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • Acute Lymphoblastic Leukemia With Failed Remission
      • São Paulo, SP, Brazil
        Instituto do Cancer do Estado de Sao Paulo
      Sep 12, 2023

      Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

      Terminated
      Has Results
      • Leukemia
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Dec 13, 2022

      Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

      Not yet recruiting
      • Lymphoblastic Leukemia
      • Palo Alto, California
        Stanford University
      Apr 27, 2023

      Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

      Not yet recruiting
      • Refractory Acute Lymphoblastic Leukemia
      • Relapsed Acute Lymphoblastic Leukemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Aug 23, 2022

      Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

      Completed
      Has Results
      • Acute Lymphoblastic Leukemia
      • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
      • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 26, 2022

      Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

      Completed
      • Refractory Acute Lymphoblastic Leukemia
      • Relapsed Acute Lymphoblastic Leukemia
      • Miami, Florida
        University of Miami
      Oct 19, 2022

      Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

      Completed
      Has Results
      • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
      • Recurrent Childhood B-Lymphoblastic Lymphoma
      • San Diego, California
      • +2 more
      Sep 13, 2022

      Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • Boston, Massachusetts
      • +14 more
      Jul 25, 2022

      Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

      Not yet recruiting
      • Recurrent Acute Leukemia of Ambiguous Lineage
      • +5 more
      • Biospecimen Collection
      • +12 more
      • (no location specified)
      Mar 8, 2023

      Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

      Completed
      Has Results
      • Lymphoblastic Lymphoma
      • San Diego, California
      • +1 more
      Jun 7, 2022

      Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Lymphoblastic Lymphoma
      • Frankfurt (Main), Germany
        University Hospital of Frankfurt (Main)
      Jul 1, 2022

      Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

      Terminated
      • Acute Lymphocytic Leukemia
      • Adult Lymphoblastic Lymphoma
      • La Jolla, California
      • +3 more
      Apr 26, 2022

      Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

      Completed
      • Acute Lymphoblastic Leukemia
      • San Francisco, California
      • +7 more
      Aug 5, 2022

      Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Acute Lymphoblastic Lymphoma
      • Palo Alto, California
      • +6 more
      May 2, 2022

      B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • Biospecimen Collection
      • +19 more
      • (no location specified)
      Nov 8, 2023

      B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

      Recruiting
      • B Acute Lymphoblastic Leukemia
      • Ph-Like Acute Lymphoblastic Leukemia
      • Duarte, California
        City of Hope Medical Center
      Jul 26, 2022

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

      Recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 2, 2022

      T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

      Recruiting
      • T Acute Lymphoblastic Leukemia
      • T Lymphoblastic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 11, 2023

      Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Shanghai (Methotrexate, Etoposide, Dexamethasone)

      Active, not recruiting
      • Extranodal NK/T-cell Lymphoma, Nasal Type
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Aug 19, 2021

      Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,

      Terminated
      Has Results
      • Recurrent Pediatric ALL
      • +3 more
      • Los Angeles, California
      • +4 more
      Feb 22, 2021